Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
May 31, 2024 01:05 ET
|
Regeneron Pharmaceuticals, Inc.
Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3 trials demonstrating Dupixent significantly reduced exacerbations and improved...
VEON discloses April YTD trading update at its AGM
May 31, 2024 01:00 ET
|
VEON Ltd.
VEON discloses April YTD trading update at its AGM Amsterdam, 31 May 2024 07:00 CEST – VEON April YTD 2024 Highlights Total revenue of USD 1,278 million, +8.6% YoY (+12.9% YoY in local...
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation
May 31, 2024 01:00 ET
|
Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y. and PARIS, May 31, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration (FDA) has extended by...
United States Government to Reinstate Section 301 Import Tariffs on Artificial Graphite from China
May 30, 2024 21:41 ET
|
Novonix Ltd.
BRISBANE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX”), a leading battery materials and technology company, today applauded the recent announcement...
Pineapple Energy Announces Appointment of Chief Operating Officer
May 30, 2024 20:19 ET
|
Pineapple Energy
Pineapple Energy Announces Appointment of Chief Operating Officer
San Diego County Regional Public Safety Agencies Launch Genasys EVAC for Enhanced Emergency Communication
May 30, 2024 19:36 ET
|
Genasys Inc.
SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Genasys Inc. (NASDAQ: GNSS), the global leader in Protective Communications, is pleased to announce that the San Diego County regional area announced...
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024
May 30, 2024 18:05 ET
|
Jasper Therapeutics, Inc.
REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel...
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
May 30, 2024 17:55 ET
|
Myriad Genetics, Inc.
Next-generation-sequencing-based homologous recombination deficiency (HRD) assay based on QIAGEN’s QIAseq xHYB technology, QIAGEN Digital Insight solutions, and Myriad’s proprietary, FDA-approved...
Plug to Webcast Annual Shareholder Meeting on June 5, 2024
May 30, 2024 17:55 ET
|
Plug Power, Inc.
LATHAM, N.Y., May 30, 2024 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, invites investors and the general...
HashiCorp Announces First Quarter of Fiscal Year 2025 Financial Results
May 30, 2024 17:50 ET
|
HashiCorp, Inc.
HashiCorp Announces First Quarter of Fiscal Year 2025 Financial Results